HighTower Advisors LLC Has $313,000 Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

HighTower Advisors LLC lessened its stake in Surgery Partners, Inc. (NASDAQ:SGRYFree Report) by 11.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,878 shares of the company’s stock after selling 1,287 shares during the quarter. HighTower Advisors LLC’s holdings in Surgery Partners were worth $313,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the company. Royce & Associates LP boosted its holdings in Surgery Partners by 12.2% in the third quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after purchasing an additional 55,545 shares in the last quarter. Lombard Odier Asset Management Europe Ltd bought a new stake in Surgery Partners in the second quarter valued at about $4,163,000. Principal Financial Group Inc. acquired a new position in shares of Surgery Partners in the 3rd quarter worth approximately $1,469,000. Rhumbline Advisers boosted its stake in shares of Surgery Partners by 19.6% in the 2nd quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock valued at $3,044,000 after purchasing an additional 20,963 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in shares of Surgery Partners during the second quarter worth approximately $29,288,000.

Surgery Partners Price Performance

Surgery Partners stock opened at $21.10 on Tuesday. The stock’s 50 day moving average is $25.78 and its 200-day moving average is $27.73. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $35.29. The company has a market capitalization of $2.68 billion, a price-to-earnings ratio of -43.96, a PEG ratio of 17.40 and a beta of 2.58. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRYGet Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. During the same quarter last year, the firm posted $0.15 earnings per share. The company’s quarterly revenue was up 14.3% on a year-over-year basis. Equities research analysts expect that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently issued reports on SGRY. Macquarie reiterated an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a research report on Tuesday, November 19th. JPMorgan Chase & Co. decreased their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. KeyCorp initiated coverage on shares of Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research note on Friday, October 4th. Finally, Royal Bank of Canada reduced their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $36.56.

Check Out Our Latest Report on SGRY

Surgery Partners Company Profile

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

See Also

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRYFree Report).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.